52 results on '"Jarolim, Petr"'
Search Results
2. Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry
3. Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells
4. Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial
5. The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease
6. Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction
7. Causes of Troponin Elevation and Associated Mortality in Young Patients
8. 74-Year-old female with new monoclonal protein on serum immunofixation electrophoresis
9. Biomarkers in the IL-6 Pathway and Cardiovascular Outcomes in Patients With STEMI in LATITUDE-TIMI 60
10. Lipoprotein(a) and Benefit of Antiplatelet Therapy: Insights From the PEGASUS-TIMI 54 Trial
11. Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
12. Plasma Corin Decreases After Coronary Artery Bypass Graft Surgery and Is Associated With Postoperative Heart Failure: A Pilot Study
13. CONCURRENT EVALUATION OF HSTNI AND HSTNT AND THEIR ASSOCIATIONS WITH CARDIOVASCULAR EVENTS IN 37,886 PATIENTS WITH STABLE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
14. SOLUBLE SUPPRESSION OF TUMORIGENICITY 2 (SST2) AND CARDIOVASCULAR OUTCOMES IN PERSONS WITH TYPE 2 DIABETES MELLITUS RANDOMIZED TO DAPAGLIFLOZIN OR PLACEBO: ANALYSES FROM THE DECLARE-TIMI 58 TRIAL
15. A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48
16. Exercise dynamics of cardiac biomarkers and hemoconcentration in patients with chronic systolic heart failure
17. Serial Measurement of Monocyte Chemoattractant Protein-1 After Acute Coronary Syndromes: Results From the A to Z Trial
18. GROWTH DIFFERENTIATION FACTOR-15, CLINICAL OUTCOMES, AND THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: INSIGHTS FROM THE DAPA-HF TRIAL
19. CA125 IN PATIENTS WITH HFREF AND THE EFFECT OF DAPAGLIFLOZIN: INSIGHTS FROM DAPA-HF
20. NT-PROBNP, BODY MASS INDEX, AND HEART FAILURE RISK IN CAMELLIA-TIMI 61
21. Intensive Statin Therapy and the Risk of Hospitalization for Heart Failure After an Acute Coronary Syndrome in the PROVE IT–TIMI 22 Study
22. Serum biomarkers for heart failure
23. CIRCULATING BIOMARKER PATTERNS IN PATIENTS WITH VASODILATORY CARDIOGENIC SHOCK IN THE CARDIAC INTENSIVE CARE UNIT: ANALYSIS FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY
24. TARGETED PROTEOMIC PROFILING OF CARDIOGENIC SHOCK IN THE CARDIAC INTENSIVE CARE UNIT: AN ANALYSIS FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY
25. Gene expression profiles of microvascular endothelial cells after stimuli implicated in the pathogenesis of vasoocclusion
26. Modulation of Gardos channel activity by cytokines in sickle erythrocytes
27. A TARGETED PROTEOMIC APPROACH IDENTIFIES NOVEL BIOMARKERS OF ARTERIAL THROMBOEMBOLIC RISK IN ENGAGE AF-TIMI 48
28. THE NEUROHORMONAL BASIS OF PULMONARY HYPERTENSION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
29. CARDIOVASCULAR BIOMARKERS AND HEART FAILURE RISK IN PATIENTS WITH STABLE ATHEROTHROMBOTIC DISEASE: A NESTED BIOMARKER STUDY FROM TRA 2°P-TIMI 50
30. INFLAMMATORY BIOMARKERS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH STEMI: A NESTED OBSERVATIONAL STUDY FROM LATITUDE-TIMI 60
31. Myocardial Injury and Cardiac Reserve Limitation in Heart Failure with Preserved Ejection Fraction
32. PROGNOSTIC VALUE OF BIOMARKER OF COLLAGEN TURNOVER (C-TERMINAL TELOPEPTIDE) IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES: INSIGHTS FROM MERLIN-TIMI 36
33. Modeling Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia in Transgenic Mice Using Human MYD88L256P Mutated Protein
34. WOMEN WHO EXPERIENCE MYOCARDIAL INFARCTION AT A YOUNG AGE HAVE WORSE SURVIVAL COMPARED WITH MEN
35. LIPID ABNORMALITIES IN YOUNG PATIENTS WITH MYOCARDIAL INFARCTION
36. INTERLEUKIN-6 AND THE RISK OF ADVERSE OUTCOMES IN PATIENTS AFTER AN ACUTE CORONARY SYNDROME: OBSERVATIONS FROM THE SOLID-TIMI 52 TRIAL
37. Diagnostic Performance of ST2 for Differentiating Cardiogenic versus Non-Cardiogenic Pulmonary Edema in Patients Presenting to the Intensive Care Unit with Hypoxic Respiratory Failure
38. ASSOCIATION OF MRP-8/14 LEVELS AND FUTURE CORONARY EVENTS IN PATIENTS WITH STABLE CAD
39. ASSOCIATION OF SVCAM-1 WITH MAJOR ADVERSE CARDIAC EVENTS IN PATIENTS WITH STABLE CAD
40. EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF AN INVESTIGATIONAL ULTRA-SENSITIVE ASSAY FOR CARDIAC TROPONIN I
41. C-TERMINAL PROVASOPRESSIN (COPEPTIN), MID-REGION PRO-ADRENOMEDULLIN (MR-PROADM) AND MID-REGION PRO-ATRIAL NATRIURETIC PEPTIDE (MR-PROANP) AS NOVEL PROGNOSTIC BIOMARKERS AFTER NON-ST ELEVATION ACUTE CORONARY SYNDROME: ANALYSIS FROM MERLIN TIMI-36
42. GALECTIN-3 AND THE DEVELOPMENT OF HEART FAILURE AFTER ACUTE CORONARY SYNDROME: A PILOT EXPERIENCE FROM PROVE IT-TIMI 22
43. Use of high sensitivity cardiac troponin assays as an adjunct to cardiac stress testing
44. Genetic Variations in CYP2B6 and Risk of Cyclophosphamide Toxicity in Patients Undergoing Myeloablative Stem Cell Transplantation.
45. Characterization of 13 Novel Band 3 Gene Defects in Hereditary Spherocytosis With Band 3 Deficiency
46. Effect of Hemoglobin Oxidation Products on the Stability of Red Cell Membrane Skeletons and the Associations of Skeletal Proteins: Correlation With a Release of Hemin
47. Mutations of Conserved Arginines in the Membrane Domain of Erythroid Band 3 Lead to a Decrease in Membrane-Associated Band 3 and to the Phenotype of Hereditary Spherocytosis
48. Band 3 Tuscaloosa: Pro327 → Arg327 Substitution in the Cytoplasmic Domain of Erythrocyte Band 3 Protein Associated With Spherocytic Hemolytic Anemia and Partial Deficiency of Protein 4.2
49. Band 3 Memphis: A Widespread Polymorphism With Abnormal Electrophoretic Mobility of Erythrocyte Band 3 Protein Caused by Substitution AAG → GAG (Lys → Glu) in Codon 56
50. CHAPTER 46 - RED BLOOD CELL MEMBRANE DISORDERS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.